Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Staging is the process of finding out how much cancer is in a person’s body and where it’s located. It’s how the doctor determines the stage of a person’s cancer.
For most types of cancer, doctors need to know how much cancer there is and where it is (among other things) to help determine the best treatment options. For example, the best treatment for an early-stage cancer may be surgery or radiation, while a more advanced-stage cancer may need treatments that reach all parts of the body, such as chemotherapy, targeted drug therapy, or immunotherapy.
Of course, the stage of a cancer isn’t the only factor used to decide which treatments might be best. Sometimes, cancers with different stages might be treated the same way, or cancers with the same stage might be treated in different ways. Many factors determine the best treatment options for each person.
A cancer’s stage can also be used to help predict the course it will likely take, as well as how likely it is that treatment will be successful. Although each person’s situation is different, cancers of the same type and stage tend to have similar outlooks.
The cancer stage is also a way for doctors to describe the extent of the cancer when they talk with each other about a person’s cancer.
Not all cancers are staged. For example, leukemias are cancers of the blood cells and therefore typically have spread throughout the body by the time they are found. Most types of leukemias aren’t staged the way cancers that form tumors are.
Different types of exams and tests can be used to figure out a cancer’s stage.
Typically, a cancer is staged when it is first diagnosed, before any treatment is given. But in some cases, it is staged again after treatment has started.
The clinical stage is an estimate of the extent of the cancer based on results of physical exams, imaging tests (x-rays, CT scans, etc.), endoscopy exams, and any biopsies that are done before treatment starts. For some cancers, the results of other tests, such as blood tests, are also used in clinical staging.
The clinical stage is often a key part of deciding the best treatment options. It can also be used when trying to get an idea of what a person’s outlook (prognosis) might be. For example, the survival rates for most types of cancer are based mainly on the stage at the time of diagnosis (see below).
If surgery to remove the cancer is the first treatment, doctors can also determine the pathological stage (also called the surgical stage). The pathological stage relies on the results of the exams and tests done before the surgery, as well as what is learned about the cancer during surgery.
Sometimes, the pathological stage is different from the clinical stage (for instance, if the surgery shows the cancer has spread more than was seen on imaging tests). The pathological stage gives more precise information, which can be used to help determine what other treatments might be needed, as well as to help predict treatment response and outcomes (prognosis).
For some cancers, some treatment other than surgery (such as chemo, targeted drug therapy, or radiation) might be done first. The goal might be to try to shrink the tumor before surgery (in which case the treatment is called neoadjuvant therapy), or it might be done as the main treatment if it’s not clear that surgery is going to be an option.
Staging might be done after this first treatment to help measure the cancer’s response to treatment. This can be done the same way as clinical staging (if surgery hasn’t been done yet), which can help determine what type of surgery should be done. Or it can be done after surgery (the same way as pathological staging), which might give more precise information.
Staging might also be done again at some point if the cancer comes back (recurs) or progresses (grows or spreads without ever having gone away completely). This information can be used to help guide decisions about further treatment.
When a cancer is staged again after the initial staging, it is sometimes referred to as restaging. Often the same tests that were done when the cancer was first diagnosed (such as physical exams, imaging tests, endoscopy exams, biopsies, and maybe surgery) are done again.
With any type of restaging, the new stage classification is added to the original stage, but it doesn’t replace it. The stage assigned at diagnosis is still the one that is most important when discussing statistics like survival rates (described below).
From a practical standpoint, however, the stage assigned to the cancer isn’t always as important as making sure everyone understands how far the cancer has spread, and what this means going forward. For example, if a person is diagnosed with a stage II cancer that later is found to have spread to other parts of the body, they (and even their health care provider) may now describe this as a ‘stage IV’ cancer, even though this isn’t technically accurate. What’s most important is that everyone understands that the cancer has spread, and that this information is used to guide future treatment decisions.
There are different types of systems used to stage cancer, but the most common and useful staging system for most types of cancer is the TNM system.
The American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC) maintain the TNM classification system as a way for doctors to stage many different types of cancer based on certain common standards.
In the TNM system, the overall stage is determined after the cancer is assigned a letter or number to describe the tumor (T), node (N), and metastasis (M) categories.
When trying to determine how much and where the cancer is in the body, doctors first look at the primary (main) tumor, which is where the cancer started. The tumor’s size, location, and whether it has grown into nearby areas can all be important. Doctors also check for other nearby tumors.
The T category can be assigned a letter or a number:
Lymph nodes near the primary tumor usually are checked to find out if cancer has spread into them. Lymph nodes are small, bean-shaped collections of immune cells. Many types of cancer often spread to nearby lymph nodes before they reach other parts of the body.
The N category can be assigned a letter or a number:
Doctors might also look at other parts of the body to see if the cancer has spread. Cancer spread to parts of the body far from the primary tumor is known as metastasis.
The M category is assigned a number:
Each cancer type has its own version of the TNM categories, so letters and numbers don’t mean the same thing for every type of cancer. For example, for some types of cancer, the T categories describe the size of the main tumor, while for others they describe how deeply the tumor has grown into the organ it started in, or whether the tumor has grown into nearby structures (regardless of its size).
For some cancer types, TNM categories may also have subcategories. These are noted with lowercase letters after the category. For example, T3a or T3b.
Some cancer types may also have fewer category options than other cancer types. For instance, some cancers may not have an N3 category.
Each of the T, N, and M categories might be written with a lowercase letter in front of it, showing if it’s a clinical or pathological classification:
For staging that is done after treatment or after cancer recurrence/progression, a category might also be given another lowercase letter in front of it:
For some cancers, the values for T, N, and M aren’t the only things that determine the stage. Some other factors that may be taken into account include:
Grade: For most cancers, the grade is a measure of how abnormal the cancer cells look under the microscope. This is also called differentiation. Grade can be important because cancers with more abnormal-looking cells tend to grow and spread faster.
The grade is usually assigned a number, with lower numbers (for example, G1) used for lower grade cancers.
Even when the grade doesn’t affect a cancer’s stage, it might still affect a person’s outlook and/or treatment.
Cell type: Cancers in some parts of the body can start in different types of cells. Because the type of cancer cell can affect treatment and outlook, it can be a factor in staging. For example, cancers of the esophagus are mainly either squamous cell cancers or adenocarcinomas. Squamous cell esophageal cancers are staged differently from esophageal adenocarcinomas.
Tumor location: For some cancers, the main tumor’s location affects outlook and is taken into account in staging. The stage of cancer of the esophagus, for example, depends on whether the cancer starts in the upper, middle, or lower third of the esophagus.
Blood levels of tumor markers: For some cancers, the blood levels of certain substances (called tumor markers or biomarkers) can affect the stage of the cancer. For example, in prostate cancer, the level of prostate-specific antigen (PSA) in the blood is taken into account in assigning a stage.
Results of tests on the cancer cells: For some cancers, lab tests done on the cancer cells are an important part of staging. For example, in breast cancer, the stage can be affected by whether or not the cancer cells have proteins called hormone receptors on them.
A person’s age: For some types of cancer, such as thyroid cancer, a person’s age at the time of diagnosis can affect their outlook, so it is taken into account when assigning a stage.
Once the values for T, N, and M (and any other factors that affect stage) have been determined, they are combined to assign an overall stage.
For most cancers, the stage is a Roman numeral from I (1) to IV (4). Stage I cancers are less advanced and often have a better prognosis (outlook). Higher stage cancers typically have spread farther (or have other concerning features), so they might require more intense (or different kinds of) treatment. Sometimes stages are subdivided as well, using capital letters (for example, stage III might be subdivided into stages IIIA and IIIB).
Some cancers also have a stage 0, which is often called carcinoma in situ. This means the cancer is still only in the layer of cells where it first started, and it has not spread any farther.
Not all cancers are staged using the TNM system. For example:
Along with the type of cancer a person has, the stage of the cancer is one of the most important factors when doctors try to determine a person’s prognosis (outlook).
For many types of cancer, prognosis is often expressed as a survival rate. This is the percentage of people with a certain type and stage of cancer who are still alive a certain amount of time (usually 5 years) after being diagnosed. For example, if the 5-year survival rate for a certain type and stage of cancer is 80%, it means that 80 out of 100 people who have that type and stage of cancer will still be expected to be alive after 5 years.
Survival rates can’t tell for sure what will happen with any particular person, because many other factors can also affect prognosis (see below). But they can give doctors and patients a general idea of how likely it is that treatment will be successful.
Survival rates are nearly always based on the stage of the cancer at the time of diagnosis. These numbers don’t apply if the cancer is restaged later on. For example, the 5-year survival rate of a cancer that is initially diagnosed as stage II and later spreads to another part of the body is not necessarily the same as that for a cancer that is initially diagnosed as a stage IV cancer (because it had already spread to another part of the body when first diagnosed).
This is important to understand because the information on our pages that discusses survival statistics refers to the stage when the cancer was first diagnosed.
It’s also important to understand that while the stage of the cancer is important, many other factors can also affect a person’s outlook. Depending on the cancer type, other important prognostic factors might include:
If you have questions about survival rates and how they might be affected by the stage of your cancer or other factors, be sure to talk to your cancer care team.
Doctors are always learning more about cancer, how it grows and spreads, and how best to treat it. Over time, some of these findings are added to the staging systems for different types of cancer, which helps make them more accurate and valuable to both doctors and patients.
At the same time, adding these newer findings often makes the staging systems more complex than they were in the past, which can make it harder for people to understand them.
If you’re not sure about the stage of your cancer or what it might mean for you, ask your doctor to explain it to you in a way you understand.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 715-725.
National Cancer Institute. Cancer Staging. 2015. Accessed at https://www.cancer.gov/about-cancer/diagnosis-staging/staging on June 12, 2020.
Last Revised: February 18, 2022
Donate now so we can continue to provide access to critical cancer information, resources, and support to improve lives of people with cancer and their families.